SCHEMBL6921768

SCHEMBL6921768

COC(Oc1cccc([N+](=O)[O-])c1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
TP53 P04637 1/20 0.47
F2 P00734 1/20 0.47
LMNA P02545 2/20 0.46
MAOB P27338 1/20 0.46
TSHR P16473 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6928014 0.87 ALDH1A1 (0.49) ALDH1A1F2LMNAMAOBTSHR
SCHEMBL4998342 0.82 LMNA (0.54) ALDH1A1TP53F2LMNATSHR
SCHEMBL16097479 0.79 LMNA (0.48) ALDH1A1F2LMNAMAOBTSHR
SCHEMBL3010141 0.79 TP53 (0.50) ALDH1A1TP53F2LMNATSHR
SCHEMBL28226986 0.79 TP53 (0.50) ALDH1A1TP53F2LMNATSHR
SCHEMBL20299326 0.78 TSHR (0.52) ALDH1A1TP53F2LMNAMAOB
SCHEMBL8472108 0.78 SMN1; SMN2 (0.52) ALDH1A1TP53F2MAOBCHRNB2
SCHEMBL7535846 0.78 TP53 (0.46) ALDH1A1TP53F2LMNATSHR
SCHEMBL28849410 0.78 LMNA (0.53) LMNATSHRCES2CES1MEN1
SCHEMBL7671999 0.78 TSHR (0.55) ALDH1A1TP53F2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001766-B1 COMPOUNDS FOR THE TREATMENT OF CCR5-MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP disclosed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed